BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 33490289)

  • 1. Blocking Interleukin-33 Alleviates the Joint Inflammation and Inhibits the Development of Collagen-Induced Arthritis in Mice.
    Li Y; Fu Y; Chen H; Liu X; Li M
    J Immunol Res; 2020; 2020():4297354. PubMed ID: 33490289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of cannabinoid receptor 2 attenuates synovitis and joint distruction in collagen-induced arthritis.
    Gui H; Liu X; Liu LR; Su DF; Dai SM
    Immunobiology; 2015 Jun; 220(6):817-22. PubMed ID: 25601571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
    Joosten LA; Helsen MM; Saxne T; van De Loo FA; Heinegard D; van Den Berg WB
    J Immunol; 1999 Nov; 163(9):5049-55. PubMed ID: 10528210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sinomenine Inhibits the Progression of Rheumatoid Arthritis by Regulating the Secretion of Inflammatory Cytokines and Monocyte/Macrophage Subsets.
    Liu W; Zhang Y; Zhu W; Ma C; Ruan J; Long H; Wang Y
    Front Immunol; 2018; 9():2228. PubMed ID: 30319663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis.
    Palmer G; Talabot-Ayer D; Lamacchia C; Toy D; Seemayer CA; Viatte S; Finckh A; Smith DE; Gabay C
    Arthritis Rheum; 2009 Mar; 60(3):738-49. PubMed ID: 19248109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis.
    Bai F; Tian H; Niu Z; Liu M; Ren G; Yu Y; Sun T; Li S; Li D
    Int J Mol Med; 2014 Mar; 33(3):711-21. PubMed ID: 24378614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The suppressive effects of Saposhnikovia divaricata (Fangfeng) chromone extract on rheumatoid arthritis via inhibition of nuclear factor-κB and mitogen activated proteinkinases activation on collagen-induced arthritis model.
    Kong X; Liu C; Zhang C; Zhao J; Wang J; Wan H; Zhu H; Zhang P; Chen W; Xiao Y; Lin N
    J Ethnopharmacol; 2013 Jul; 148(3):842-50. PubMed ID: 23711830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of pathogenic IL-17 responses in collagen-induced arthritis: roles of endogenous interferon-gamma and IL-4.
    Sarkar S; Cooney LA; White P; Dunlop DB; Endres J; Jorns JM; Wasco MJ; Fox DA
    Arthritis Res Ther; 2009; 11(5):R158. PubMed ID: 19852819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tumor necrosis factor-related apoptosis-inducing ligand on the reduction of joint inflammation in experimental rheumatoid arthritis.
    Jin CH; Chae SY; Kim TH; Yang HK; Lee EY; Song YW; Jo DG; Lee KC
    J Pharmacol Exp Ther; 2010 Mar; 332(3):858-65. PubMed ID: 19933369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-angiogenic effect of Shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways.
    Liu C; He L; Wang J; Wang Q; Sun C; Li Y; Jia K; Wang J; Xu T; Ming R; Wang Q; Lin N
    J Ethnopharmacol; 2020 Oct; 260():113039. PubMed ID: 32497675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-35 (IL-35) inhibits proliferation and promotes apoptosis of fibroblast-like synoviocytes isolated from mice with collagen-induced arthritis.
    Li Y; Wu S; Li Y; Jiang S; Lin T; Xia L; Shen H; Lu J
    Mol Biol Rep; 2016 Sep; 43(9):947-56. PubMed ID: 27379996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theaflavin-3, 3'-Digallate Attenuates Rheumatoid Inflammation in Mice Through the Nuclear Factor-κB and MAPK Pathways.
    Liu W; Li J
    Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):153-160. PubMed ID: 30874838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic Resolvin E1 (RvE1) Treatment Does Not Ameliorate the Severity of Collagen-Induced Arthritis (CIA) in Mice: A Randomized, Prospective, and Controlled Proof of Concept Study.
    de Molon RS; Thurlings RM; Walgreen B; Helsen MM; van der Kraan PM; Cirelli JA; Koenders MI
    Mediators Inflamm; 2019; 2019():5689465. PubMed ID: 31780864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L161982 alleviates collagen-induced arthritis in mice by increasing Treg cells and down-regulating Interleukin-17 and monocyte-chemoattractant protein-1 levels.
    Chen L; Wu X; Zhong J; Li D
    BMC Musculoskelet Disord; 2017 Nov; 18(1):462. PubMed ID: 29145862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR3 antagonist NBI-74330 mitigates joint inflammation in Collagen-Induced arthritis model in DBA/1J mice.
    Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Alomar HA; Al-Mazroua HA; Ibrahim KE; Alshamrani AA; Al-Hamamah MA; Alfardan AS; Attia SM
    Int Immunopharmacol; 2023 May; 118():110099. PubMed ID: 37018975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effects of interleukin-1β and interleukin-17A antibodies on collagen-induced arthritis mouse model.
    Zhang Y; Ren G; Guo M; Ye X; Zhao J; Xu L; Qi J; Kan F; Liu M; Li D
    Int Immunopharmacol; 2013 Feb; 15(2):199-205. PubMed ID: 23280345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinsenoside inhibits the inflammatory mediator release in a type-II collagen induced arthritis mouse model by regulating the T cells responses.
    Hsiao HB; Hsieh CC; Wu JB; Lin H; Lin WC
    BMC Complement Altern Med; 2016 Feb; 16():80. PubMed ID: 26916550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dextromethorphan Exhibits Anti-inflammatory and Immunomodulatory Effects in a Murine Model of Collagen-Induced Arthritis and in Human Rheumatoid Arthritis.
    Chen DY; Lin CC; Chen YM; Chao YH; Yang DH
    Sci Rep; 2017 Sep; 7(1):11353. PubMed ID: 28900117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.